Simply Wall St.27d agoneutral
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical CatalystsLooking for biotech stocks with upside that could help people fight illness? Here are three that analysts think might be worth a look.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
145last 24h
874last 7d
145● bullish (7d)
96● bearish (7d)
214publishers
Benzinga35d agoneutral
Edesa Biotech Stock Sinks After Fresh Capital RaiseEdesa Biotech, Inc. (NASDAQ:EDSA) shares fell nearly 13% in Thursday premarket trading after the company priced a $25 million public stock offering. Edesa Biotech shares fell 18.27% to $4.70 in Wednesday’s after-market session, putting the stock on traders’ radars. The move followed the company’s Q3 earnings release, which came out four days earlier, according to Benzinga’s after-hours movers recap. What Is Edesa Biotech’s Financing Deal? Edesa is raising fresh capital via an equity offering of
MT Newswires111d agoneutral
Sector Update: Healthcare Stocks Gain Friday AfternoonHealthcare stocks rose Friday afternoon, with the NYSE Healthcare Index increasing 1.2% and the Stat
Insider Monkey157d agoneutral
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo TreatmentEdesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical study of EB06, which is a treatment for moderate-to-severe nonsegmental vitiligo, is […]
Associated Press Finance212d agoneutral
BC-Most Active StocksElong Power Holding Ltd. 49,425,228 0.49
Simply Wall St.331d agoneutral
Favourable Signals For Edesa Biotech: Numerous Insiders Acquired StockUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...